Richard Scott Struthers insider trades: Crinetics Pharmaceuticals (CRNX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | CRNX | ↓ Sell | 21,981 | $37.37 | $822K | Direct | Mar 18, 2026 (2d) |
| Sep 26, 2025 | CRNX | ↓ Sell | 4,000 | $45.00 | $180K | By Family Trust 2 | Sep 30, 2025 (4d) |
| Mar 19, 2025 | CRNX | ↓ Sell | 17,338 | $34.20 | $593K | Direct | Mar 21, 2025 (2d) |
| Dec 2, 2024 | CRNX | ↓ Sell | 10,000 | $57.57 | $576K | By Family Trust 4 | Dec 4, 2024 (2d) |
| May 8, 2024 | CRNX | ↓ Sell | 107,448 | $49.40 | $5.3M | Direct | May 10, 2024 (2d) |
| Apr 4, 2024 | CRNX | ↓ Sell | 40,951 | $49.17 | $2.0M | Direct | Apr 8, 2024 (4d) |
| Nov 3, 2023 | CRNX | ↓ Sell | 200,000 | $30.56 | $6.1M | Direct | Nov 6, 2023 (3d) |
| Jul 13, 2023 | CRNX | ↓ Sell | 50,000 | $20.21 | $1.0M | By Family Trust 1 | Jul 13, 2023 (0d) |
| Jun 16, 2023 | CRNX | ↓ Sell | 50,000 | $20.81 | $1.0M | By Family Trust 1 | Jun 21, 2023 (5d) |
| Apr 13, 2022 | CRNX | ↓ Sell | 138,643 | $26.83 | $3.7M | By Family Trust 1 | Apr 15, 2022 (2d) |
| Apr 5, 2022 | CRNX | ↓ Sell | 21,357 | $25.34 | $541K | By Family Trust 1 | Apr 7, 2022 (2d) |
| Sep 7, 2021 | CRNX | ↓ Sell | 10,000 | $25.00 | $250K | By Family Trust 4 | Sep 9, 2021 (2d) |
| Sep 7, 2021 | CRNX | ↓ Sell | 10,000 | $25.00 | $250K | By Family Trust 2 | Sep 9, 2021 (2d) |
| Sep 7, 2021 | CRNX | ↓ Sell | 10,000 | $25.00 | $250K | By Family Trust 3 | Sep 9, 2021 (2d) |
| Dec 3, 2020 | CRNX | ↑ Buy | 4,000 | $13.10 | $52K | Direct | Dec 4, 2020 (1d) |
| Dec 2, 2020 | CRNX | ↑ Buy | 1,000 | $12.60 | $13K | By Spouse | Dec 4, 2020 (2d) |
| Jul 16, 2020 | CRNX | ↓ Sell | 35,000 | $14.88 | $521K | By Family Trust 1 | Jul 17, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRNX insiders
Open-market trades in the last 12 months
About Richard Scott Struthers's insider trades
Richard Scott Struthers is President & CEO at Crinetics Pharmaceuticals (CRNX). Since Jul 16, 2020, Richard has reported 2 open-market purchases worth $65K and 15 sales worth $23.2M on SEC Form 4. In the last 12 months: 1 sale ($822K).
Their filings also include option exercises (11 filings), grants and awards (8 filings), gifts (5 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.